<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01440894</url>
  </required_header>
  <id_info>
    <org_study_id>TranstekGBFA11003</org_study_id>
    <secondary_id>BTS-TRANS03</secondary_id>
    <nct_id>NCT01440894</nct_id>
  </id_info>
  <brief_title>Clinical Trail of Transtek Glass Body Fat Analyzer</brief_title>
  <acronym>GBFA</acronym>
  <official_title>Verify the Functions and Efficiency of Transtek Glass Body Fat Analyzer, GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, GBF-950-D.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leo Wang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BTS International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>BTS International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical protocol of the clinical testing of this device:

        1. Objective of the test: To verify the functions and efficiency of devices.

        2. Test methods and procedures: Comparison Test.

        3. DUT(Device Under Test): Transtek Glass Body Fat Analyzer, Model: GBF-733-W1, GBF-1012,
           BF-1039, BF-1041-A, and GBF-950-D.

        4. Comparison device: Transtek Glass Body Analyzer, GBF-950 (Predicate Device).

        5. Study endpoints: Transtek devices and the predicate device are substantial equivalence.

        6. Statistical methodology used: Description of statistical methods.

        7. Result: Efficiencies of Transtek devices and predicate device are in the same level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hospital Information The data was collected by Zhongshan City People's Hospital Clinical
      Investigator Team at Zhongshan City People's Hospital, No.2 Sunwen Dong Road, Zhongshan,
      Guangdong 528403, P. R. China.

      Investigator: Dr. Stephen Feng, Leader; Fan Futao, Nurse A; Wu Yanting, Nurse B.

      Contact Dr. James Zhu Tel: +86 760 88823818 Used Equipments DUT (Device Under Test): Transtek
      Glass Body Fat Analyzer, Model: GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, and GBF-950-D.

      Reference Device: Transtek Glass Body Analyzer, GBF-950 (Predicate Device). Test Protocol

        1. Test Purpose:

           The aim of clinical test is to collect weight, body fat, total body water, bone mass,
           and muscle mass reading value which measured by DUT and reference device.

           Note: GBF-733-W1 and BF-1039 have not bone mass functions. So it just collects weight,
           body fat, total body water, and muscle mass data.

        2. Target Subject:

           The subject database shall contain at least 25 male and 25 female subjects and all above
           18 years old. Patient's population analysis is bellow.

        3. Test procedures 1) Record the name, age, and gender values of each subject. 2) Let
           subject seated calmly for two minutes before test, dry the feet. 3) Use device to
           measure weight, body fat, total body water, bone mass, and muscle mass; record reading
           value.

      4) For each subject, repeat 3) to get 3 pairs measurements. 5) Repeat step 1) to 4) for every
      device (DUT: GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, and GBF-950-D; and reference device:
      GBF-950).

      6) Repeat step 1) to 5) for each subject. 5. Note:

        1. No motion and speaking are allowed during the measurement.

        2. All DUT use the same algorithms, have the same number of electrodes and contact the
           patient at the same body locations (feet), and operate on the same frequency.

        3. Test environment: Temperature: 22±1℃; Relative humidity: 40~50%.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Verify the accuracy of measure functions of device</measure>
    <time_frame>8 days</time_frame>
    <description>Verify the functions and efficiency of these devices compare with a specified product.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Weight</condition>
  <condition>Body Fat Disorder</condition>
  <condition>Bone Mass</condition>
  <arm_group>
    <arm_group_label>Body Analysis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comparison test</intervention_name>
    <description>Reference Device: Transtek Glass Body Analyzer, GBF-950, accuracy: ±0.1kg and range: 0-180kg.
DUT(Device Under Test): Transtek Glass Body Fat Analyzer, Model: GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, and GBF-950-D.</description>
    <arm_group_label>Body Analysis</arm_group_label>
    <other_name>Brand name: Transtek</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The subject population included patients whose age is above 18 years old. Male or Female.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male,female

        Exclusion Criteria:

          -  below 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Feng, Director</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan City People's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan City People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <zip>528403</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.zsph.com/</url>
    <description>Related Info</description>
  </link>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2011</study_first_submitted>
  <study_first_submitted_qc>September 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2011</study_first_posted>
  <last_update_submitted>September 25, 2011</last_update_submitted>
  <last_update_submitted_qc>September 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>BTS International</investigator_affiliation>
    <investigator_full_name>Leo Wang</investigator_full_name>
    <investigator_title>Team leader</investigator_title>
  </responsible_party>
  <keyword>weight</keyword>
  <keyword>body fat</keyword>
  <keyword>total body water</keyword>
  <keyword>bone mass</keyword>
  <keyword>muscle mass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

